GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases

NCT01480583 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Brain Metastases

Interventions

DRUG: GRN1005
DRUG: Trastuzumab
DRUG: 18F-FLT

Sponsor

Angiochem Inc